{"entity":{"type":"insider","cik":"0001967910","url":"/insider/0001967910","json_url":"/insider/0001967910.json","name":"Umstead John W. V","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2024-01-08","last":"2024-07-08","span_basis":"filed_date"},"name_variants":[{"name":"Umstead John W. V","source":"filing","n_filings":4,"first_seen":"2024-01-08","last_seen":"2024-07-08"}],"transactions":[{"id":3208381,"accession":"0001562180-24-005656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-005656","line_url":"/filing/0001562180-24-005656#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001967910","owner_name":"Umstead John W. V","owner_display_name":"Umstead John W. V","owner_url":"/insider/0001967910","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":527.0,"shares_display":"527","price_per_share":2.5077,"price_display":"2.51","price_state":"stated","total_value":1321.5579,"total_display":"1,321.56","total_whole":"1,322","shares_owned_after":187718.0,"shares_owned_after_display":"187,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-08","scope":"insider"},{"id":2427349,"accession":"0001562180-24-004063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-004063","line_url":"/filing/0001562180-24-004063#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001967910","owner_name":"Umstead John W. V","owner_display_name":"Umstead John W. V","owner_url":"/insider/0001967910","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8151.0,"shares_display":"8,151","price_per_share":4.7888,"price_display":"4.79","price_state":"stated","total_value":39033.5088,"total_display":"39,033.51","total_whole":"39,034","shares_owned_after":153245.0,"shares_owned_after_display":"153,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-05-15","scope":"insider"},{"id":2113596,"accession":"0001562180-24-002880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-002880","line_url":"/filing/0001562180-24-002880#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001967910","owner_name":"Umstead John W. V","owner_display_name":"Umstead John W. V","owner_url":"/insider/0001967910","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6547.0,"shares_display":"6,547","price_per_share":3.0169,"price_display":"3.02","price_state":"stated","total_value":19751.6443,"total_display":"19,751.64","total_whole":"19,752","shares_owned_after":123896.0,"shares_owned_after_display":"123,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-20","scope":"insider"},{"id":2693989,"accession":"0001562180-24-000328","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-24-000328","line_url":"/filing/0001562180-24-000328#line-4","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001967910","owner_name":"Umstead John W. V","owner_display_name":"Umstead John W. V","owner_url":"/insider/0001967910","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111.0,"shares_display":"111","price_per_share":2.9423,"price_display":"2.94","price_state":"stated","total_value":326.5953,"total_display":"326.60","total_whole":"327","shares_owned_after":130443.0,"shares_owned_after_display":"130,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-08","scope":"insider"},{"id":2693984,"accession":"0001562180-24-000328","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-24-000328","line_url":"/filing/0001562180-24-000328","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001967910","owner_name":"Umstead John W. V","owner_display_name":"Umstead John W. V","owner_url":"/insider/0001967910","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":632.0,"shares_display":"632","price_per_share":3.1189,"price_display":"3.12","price_state":"stated","total_value":1971.1448,"total_display":"1,971.14","total_whole":"1,971","shares_owned_after":130554.0,"shares_owned_after_display":"130,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2024-01-08","last_seen":"2024-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001967910","retrieved_at":"2026-08-23T05:31:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}